GlaxoSmithKline Pakistan Overview
- Year Founded
-
1950
- Status
-
Public
- Employees
-
1,690
- Stock Symbol
-
GLAXO
- Share Price
-
$1.66
- (As of Tuesday Closing)
GlaxoSmithKline Pakistan General Information
Description
GlaxoSmithKline Pakistan Ltd is engaged in the research, development, and manufacturing of pharmaceutical medicines, vaccines, and consumer healthcare products. It is involved in Anti-infective, Respiratory, Vaccines, Dermatological, Gastrointestinal, Analgesics, Urology, Central Nervous System, Allergy, Cardiovascular, and Vitamins therapy areas. The operating business divisions are Pharmaceuticals and Consumer Healthcare. The pharmaceutical brands of the company include Augmentin, Seretide, Amoxicillin, Velosef, Zantac, and Calpol, and prominent vaccines include Synflorix, Infanrix Hexa, Rotarix, Engerix-B, Havrix, and Cervarix. The company derives maximum revenue from the Pharmaceuticals segment.
Contact Information
Website
www.pk.gsk.comCorporate Office
- 35, Dockyard Road
- West Wharf
- Karachi, 74000
- Pakistan
Corporate Office
- 35, Dockyard Road
- West Wharf
- Karachi, 74000
- Pakistan
GlaxoSmithKline Pakistan Stock Performance
As of 22-Apr-2025, GlaxoSmithKline Pakistan’s stock price is $1.66. Its current market cap is $528M with 318M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.66 | $1.62 | $0.34 - $1.71 | $528M | 318M | 413K | $0.07 |
GlaxoSmithKline Pakistan Financials Summary
As of 31-Dec-2024, GlaxoSmithKline Pakistan has a trailing 12-month revenue of $219M.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 428,331 | 428,331 | 80,859 | 90,583 |
| Revenue | 218,687 | 218,687 | 177,032 | 203,046 |
| EBITDA | 39,644 | 39,644 | 9,875 | 24,773 |
| Net Income | 23,360 | 23,360 | 1,903 | 11,952 |
| Total Assets | 161,013 | 161,013 | 136,096 | 155,751 |
| Total Debt | 621 | 621 | 542 | 271 |
GlaxoSmithKline Pakistan Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
GlaxoSmithKline Pakistan Comparisons
Industry
Financing
Details
GlaxoSmithKline Pakistan Competitors (8)
One of GlaxoSmithKline Pakistan’s 8 competitors is Johnson & Johnson, a Corporation company based in New Brunswick, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Johnson & Johnson | Corporation | New Brunswick, NJ | ||||
| Zydus Lifesciences | Corporation | Ahmedabad, India | ||||
| AstraZeneca | Formerly PE-Backed | Cambridge, United Kingdom | ||||
| Takeda Pharmaceutical | Corporation | Tokyo, Japan | ||||
| Teva Pharmaceutical Industries | Corporation | Tel Aviv, Israel |
GlaxoSmithKline Pakistan Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
GlaxoSmithKline Pakistan ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
GlaxoSmithKline Pakistan FAQs
-
When was GlaxoSmithKline Pakistan founded?
GlaxoSmithKline Pakistan was founded in 1950.
-
Where is GlaxoSmithKline Pakistan headquartered?
GlaxoSmithKline Pakistan is headquartered in Karachi, Pakistan.
-
What is the size of GlaxoSmithKline Pakistan?
GlaxoSmithKline Pakistan has 1,690 total employees.
-
What industry is GlaxoSmithKline Pakistan in?
GlaxoSmithKline Pakistan’s primary industry is Food Products.
-
Is GlaxoSmithKline Pakistan a private or public company?
GlaxoSmithKline Pakistan is a Public company.
-
What is GlaxoSmithKline Pakistan’s stock symbol?
The ticker symbol for GlaxoSmithKline Pakistan is GLAXO.
-
What is the current stock price of GlaxoSmithKline Pakistan?
As of 22-Apr-2025 the stock price of GlaxoSmithKline Pakistan is $1.66.
-
What is the current market cap of GlaxoSmithKline Pakistan?
The current market capitalization of GlaxoSmithKline Pakistan is $528M.
-
What is GlaxoSmithKline Pakistan’s current revenue?
The trailing twelve month revenue for GlaxoSmithKline Pakistan is $219M.
-
Who are GlaxoSmithKline Pakistan’s competitors?
Johnson & Johnson, Zydus Lifesciences, AstraZeneca, Takeda Pharmaceutical, and Teva Pharmaceutical Industries are some of the 8 competitors of GlaxoSmithKline Pakistan.
-
What is GlaxoSmithKline Pakistan’s annual earnings per share (EPS)?
GlaxoSmithKline Pakistan’s EPS for 12 months was $0.07.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
